Ala Hssain | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Ala Hssain | Drug Discovery and Development | Best Researcher Award

Ms Ala Hssain,University of Halabja,Iraq

Dr. Ala Hamd Hssain 🇮🇶 is a dedicated physicist specializing in material science and quantum mechanics. She earned her PhD in Material Science (2023) from Firat University, Turkey, and her Master’s in Quantum Mechanics (2014) from Eastern Mediterranean University, Cyprus. Currently, she is a faculty member at University of Halabja, Iraq, teaching quantum mechanics and advanced calculus. Her research focuses on DFT simulations, molecular modeling, and hydroxyapatite materials, with numerous publications in high-impact journals 📚. Proficient in Gaussian, Vesta, and Multiwfn, she actively contributes to scientific advancements in computational and experimental physics. ✨

Publication Profile

Scopus

Education

Ms. Ala Hssain 🎓 earned her Ph.D. in Material Science (2019-2023) from Firat University, Faculty of Science, Physics Department, in Elazig, Turkey 🇹🇷. She previously completed her Master’s degree in Quantum Mechanics (2012-2014) at Eastern Mediterranean University, Cyprus 🇨🇾, under the supervision of Prof. Dr. Habib Mazharimousavi. Her academic journey began with a Bachelor’s degree in Physics from Salahaddin University 🎓. With a strong foundation in physics and material science, she has dedicated her research to advancing knowledge in these fields, contributing to cutting-edge developments in quantum mechanics and material engineering. ⚛️🔬

Academic Experience

Ms. Ala Hssain 🎓 has a rich background in teaching and laboratory assistance. She served as an assistant physicist at the University of Sulaimani 🔬, working in optics, electricity, and measurement labs (2009-2010), solid-state and atomic labs (2010-2011), and atomic labs (2011-2012). Later, she became a lecturer at the University of Halabja 📚, teaching Calculus, scientific debate, atomic labs, metrology, and electricity & magnetism between 2014 and 2018. Currently, she continues her academic journey as a Quantum Mechanics professor ⚛️ for third-year students at the University of Halabja, contributing to the next generation of physicists. 🚀

Research Experience

Ms. Ala Hssain 🎓 is proficient in advanced computational tools for molecular simulations and density functional theory (DFT) 🔬. She has expertise in Gaussian software for molecular modeling, enabling precise quantum mechanical calculations ⚛️. Additionally, she is skilled in VESTA for 3D visualization of crystal structures 🏗️, VMD for molecular dynamics simulations 🧬, Multiwfn for wavefunction analysis 🌊, and Siesta for efficient DFT calculations on complex materials 🏢. Her expertise in these tools enhances her research in material science, quantum mechanics, and computational physics, contributing to innovative advancements in the field. 🚀

Academic Activities

Ms. Ala Hssain 🎓 has an extensive research portfolio, focusing on material science, quantum mechanics, and computational chemistry 🔬. Her publications explore hydroxyapatite co-doping, spinel synthesis, and optoelectronic compounds. Notable works include DFT modeling of Secnidazole 🧪, structural and spectroscopic studies on serotonin ⚛️, and Mg-doped Zn-based hydroxyapatites 🏗️. She has also contributed to theoretical and experimental research on L-tryptophan dimers 🧬. Published in prestigious journals like Chemical Physics Letters and Journal of Molecular Structure, her studies drive advancements in materials chemistry, nanotechnology, and molecular simulations. 🚀📖

Research Focus

Ms. Ala Hssain’s research focuses on Computational and Experimental Chemistry 🧪, particularly in the structural and spectroscopic analysis of biomolecules. Her work on the L-tryptophan dimer state involves a combination of Density Functional Theory (DFT)🖥️ and Molecular Dynamics (MD) simulations to understand molecular interactions and stability. This interdisciplinary research bridges theoretical modeling and experimental validation, contributing to fields like biophysics 🧬, pharmaceutical sciences 💊, and material chemistry 🔬. Her expertise lies in using computational tools to predict molecular behavior, aiding in drug design and biomolecular engineering. Her findings enhance the understanding of amino acid interactions in biological systems.

Publication Top Notes

Structural and spectroscopic study of L-tryptophan dimer state using DFT and MD: Computational and experimental analysis

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Published on by Top Pharmaceutical

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Prof Serefnur Ozturk, Selcuk University Faculty of Medicine, Turkey

Prof. Şerefnur Öztürk is a leading expert in Neurology and Neurointensive Care, currently serving as the Head of the Neurology Department at Selcuk University, Turkey. She has held prominent roles including Vice Dean of the Faculty of Medicine (1996-2020) and President of the Turkish Neurological Society (2014-2021). With significant international influence, she contributes to the European Academy of Neurology and World Stroke Organization. She has led pivotal projects and trials in stroke and COVID-19-related neurological care. Prof. Öztürk is an acclaimed researcher with numerous influential publications in neurology.

Publication Profile

scopus

Education

Prof. Serefnur Ozturk has an impressive educational background. She began her medical studies at Ankara University Medical Faculty, where she earned her degree between 1980 and 1987. Her academic journey continued with a prestigious NATO Fellowship at Arizona University’s Stroke Center in 1993, further enhancing her expertise. In 1998, she advanced her knowledge in neurology and intensive care at Pittsburgh University, where she studied in their renowned Neurology and Intensive Care Department. These experiences have shaped Prof. Ozturk into a leading figure in her field. 🏥🎓🧠

Internship and Residencies

Prof. Serefnur Ozturk completed her internship at Ankara University Medical Faculty, where she gained valuable hands-on experience. Following this, she pursued her residency at Ankara Numune Research and Education Hospital, further honing her medical skills. Prof. Ozturk’s dedication to her field is reflected in her board certification, earning the Turkish Neurological Board Council Certificate. This certification recognizes her extensive expertise in neurology, solidifying her status as a trusted professional in her area of specialization. Her journey through internships, residencies, and board certification showcases her commitment to excellence. 🏥💉🧑‍⚕️🧠

Experiences

Prof. Serefnur Ozturk holds numerous prestigious leadership roles in neurology. She served as the President of the Turkish Neurological Society from 2014 to 2021 and is currently a member of various important committees, including the European Academy of Neurology (EAN) COVID-19 Task Force and the World Stroke Organization Global Policy Committee. Additionally, she is the Vice President of the European Environmental Neurology Society and has held positions within the World Federation of Neurology (WFN), including President of the Migrant Neurology Specialty Group. Prof. Ozturk is dedicated to advancing stroke care, cerebrovascular diseases prevention, and diversity in neurology. 🧠🌍👩‍⚕️🏥

Projects

Prof. Serefnur Ozturk has played a pivotal role in several major clinical trials and registries. She is the Principal Investigator of the EAN ENERGY COVID-19 Registry and the ENSEMBLE study, showcasing her leadership in critical research. Additionally, Prof. Ozturk serves as the National Coordinator for the Turkish COVID-19 Registry, the ENOS Trial, and TICH-2. Her expertise extends to key studies like the PERFORM Study (Phase III), FACT (Phase IV), and NAVIGATE-ESUS, where she also holds significant leadership positions. Her contributions to clinical research have greatly impacted neurology and stroke care. 🔬🧠🌍💉

Research Focus

Prof. Şerefnur Öztürk’s research focus lies predominantly in neurology, with a special emphasis on the neurological impacts of COVID-19, ischemic stroke, and innovative prognostic tools like the Selcuk Score. Her work is pivotal in advancing the understanding of how pandemics influence neurological care and the management of post-pandemic risks. Additionally, Prof. Öztürk contributes to cutting-edge stroke prevention and rehabilitation technologies, including web-based solutions. Her contributions drive progress in neuro-COVID research, stroke management, and global neurological health policies, showcasing her commitment to improving outcomes for patients worldwide. 🌍🧠💻

Publication Top Notes

The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future

Muscle mass as a modifier of stress response in acute ischemic stroke patients

Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers — An updated European Academy of Neurology consensus statement

The Effect of Tranexamic Acid on Neurosurgical Intervention in Spontaneous Intracerebral Hematoma: Data from 121 Surgically Treated Participants from the Tranexamic Acid in IntraCerebral Hemorrhage-2 Randomized Controlled Trial

General neurology: Current challenges and future implications

Climate Change and Stroke: A Topical Narrative Review

Dvora Joseph Davey | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Dvora Joseph Davey | Clinical Trials | Best Researcher Award 

Dr Dvora Joseph Davey, University of California, Los Angeles, UCLA, South Africa

Dr. Dvora Joseph Davey is a distinguished epidemiologist with a focus on infectious diseases, particularly HIV and STIs. Holding a Ph.D. in Epidemiology from UCLA, her research, mainly in sub-Saharan Africa, aims to reduce the burden of HIV through innovative interventions. As a Principal Investigator in clinical trials, Dr. Davey has contributed significantly to global HIV prevention efforts, especially for pregnant women. She is actively involved in policy-making with groups like the WHO and NIH, shaping global health initiatives. Her leadership, extensive research, and mentorship in global health make her an exemplary figure in public health. 🌍🔬💉

Publication Profile

google scholar

scopus

orcid

Education

Dr. Dvora Joseph Davey has an impressive academic background, beginning with a B.A. in International Affairs and French from the University of Colorado, Boulder, in 1998. She went on to earn a Master of Public Health (M.P.H.) in Population and Reproductive Health Sciences from Columbia University in 2003. Dr. Davey completed her Ph.D. in Epidemiology at the University of California, Los Angeles, in 2016, followed by a fellowship in Epidemiology of HIV at the University of North Carolina in 2017. She furthered her expertise with a postdoctoral fellowship in Global HIV Prevention at UCLA in 2018. 🌍📚

Scientific Appointments

Dr. Dvora Joseph Davey has held several prestigious positions throughout her career. Currently, she serves as an Associate Professor in Infectious Diseases and Epidemiology at UCLA’s School of Medicine and School of Public Health, respectively. She also holds honorary roles at the University of Cape Town and Desmond Tutu Health Foundation. Dr. Davey’s research includes being the Principal Investigator on a study about sexual behavior and PrEP acceptability. Her past positions include HIV Director at Population Services International in Mozambique and Director at the Rwanda-Emory HIV Research Group. With her diverse roles, Dr. Davey has had a significant global impact. 🌍🩺📊

Professional Memberships

Dr. Dvora Joseph Davey has made significant contributions to the field of HIV and reproductive health, serving as an Assistant Editor for renowned journals such as AIDS, JIAS, and PloS Global Health. She is also an active member of the South African Clinical Research Association and the American Public Health Association. Her honors include invitations to present at major conferences like HIVR4P 2024 in Peru and WHO Working Group meetings. Dr. Davey has co-chaired several influential research working groups, including on PrEP in pregnancy, and received multiple awards, including UCLA’s Epidemiology Department Summer Fellowship. 🌍📚🎤

Awards

Dr. Dvora Joseph Davey is a renowned researcher whose work focuses on HIV prevention and treatment, particularly in pregnant and breastfeeding women. Her studies address key challenges in high HIV incidence communities, especially in Sub-Saharan Africa. Dr. Davey investigates Pre-exposure Prophylaxis (PrEP) access, adherence, and effectiveness among pregnant women, emphasizing the need for female-controlled HIV prevention methods during vulnerable periods. Additionally, she explores the integration of STI testing, alcohol use, and the impact of intimate partner violence on HIV risk. Her contributions significantly influence HIV-related healthcare policies, aiming to reduce transmission and improve outcomes in these populations. 👩‍🔬🌍💉

Policy Involvement

Dr. Dvora Joseph Davey has made significant contributions to national and international HIV and STI policy-making. Her leadership in key working groups, including the National PrEP and Prevention of Vertical Transmission of HIV Working Groups, as well as the World Health Organization’s Working Group on Long-Acting PrEP in pregnancy, highlights her expertise and influence. These positions enable Dr. Davey to play a pivotal role in translating scientific research into actionable policies, ensuring her work impacts not only the scientific community but also global health policies. Her efforts amplify the reach of her research, making a lasting impact on public health worldwide. 🌍🩺💉

Leadership

Dr. Dvora Joseph Davey’s leadership in managing large-scale clinical trials and mentoring emerging public health and epidemiology professionals showcases her dedication to education and capacity-building in global public health. As a recipient of the prestigious NIH/Fogarty International Research Scientist Development Award (IRSDA) and the follow-on R01 award, Dr. Davey has solidified her position as a thought leader in the field. Her commitment to fostering continuous learning and improvement within the global health community reflects her deep influence and dedication to advancing public health practices worldwide. 🎓🌍💉👩‍🔬

Ongoing Projects

Dr. Dvora Joseph Davey’s ongoing research, supported by NIH and Gilead Corporation, plays a crucial role in addressing HIV within vulnerable populations. Her work on projects like PrEP-PP and SCOPE-PP, alongside innovative initiatives such as a community-based peer-led intervention to tackle alcohol use and HIV risk in pregnant women, highlights her proactive approach to solving complex public health challenges. Dr. Davey’s research aims to create effective, targeted solutions that address the unique needs of at-risk communities, contributing significantly to advancing HIV prevention and care efforts. 💡🧑‍🔬🩺🌍

Research Focus

Dr. Dvora Joseph Davey is a prominent researcher specializing in HIV prevention, sexually transmitted infections (STIs), and maternal health. Her work focuses on pre-exposure prophylaxis (PrEP) for HIV, examining its safety and efficacy among pregnant and postpartum women. She also explores STI diagnostics, point-of-care testing, and the prevalence of curable STIs in low- and middle-income countries. Her research seeks to improve access to health interventions, particularly for vulnerable populations like men who have sex with men and transgender women. Dr. Davey’s contributions help shape public health strategies for HIV prevention and sexual health. 🦠💉

Publication Top Notes